X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3259) 3259
Book Review (297) 297
Publication (158) 158
Book / eBook (46) 46
Book Chapter (19) 19
Magazine Article (4) 4
Conference Proceeding (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2988) 2988
humans (2316) 2316
male (1721) 1721
female (1574) 1574
middle aged (1098) 1098
animals (1058) 1058
organometallic compounds - adverse effects (978) 978
adult (923) 923
aged (834) 834
organometallic compounds - therapeutic use (790) 790
organometallic compounds (738) 738
organometallic compounds - administration & dosage (642) 642
radiology, nuclear medicine & medical imaging (528) 528
organometallic compounds - pharmacology (419) 419
rats (415) 415
magnetic resonance imaging (413) 413
treatment outcome (372) 372
contrast media (365) 365
organometallic compounds - toxicity (340) 340
gadolinium (322) 322
adolescent (305) 305
aged, 80 and over (286) 286
organometallic compounds - chemistry (285) 285
mice (283) 283
abridged index medicus (278) 278
time factors (272) 272
contrast media - adverse effects (266) 266
pharmacology & pharmacy (254) 254
toxicology (254) 254
meglumine - adverse effects (245) 245
dose-response relationship, drug (242) 242
prospective studies (241) 241
toxicity (232) 232
organometallic compounds - pharmacokinetics (229) 229
medicine & public health (224) 224
oncology (217) 217
magnetic resonance imaging - methods (202) 202
gadolinium dtpa (199) 199
child (197) 197
biochemistry & molecular biology (191) 191
contrast media - administration & dosage (188) 188
gastroenterology & hepatology (188) 188
analysis (174) 174
safety (168) 168
drug therapy, combination (167) 167
cancer (165) 165
care and treatment (163) 163
meglumine - administration & dosage (157) 157
young adult (151) 151
research (149) 149
helicobacter infections - drug therapy (146) 146
risk factors (144) 144
health aspects (143) 143
meglumine - therapeutic use (142) 142
retrospective studies (139) 139
therapy (138) 138
efficacy (131) 131
antiprotozoal agents - adverse effects (130) 130
rats, wistar (130) 130
meglumine - analogs & derivatives (129) 129
child, preschool (128) 128
oxidative stress (128) 128
antiprotozoal agents - therapeutic use (127) 127
meglumine antimoniate (120) 120
leishmaniasis, cutaneous - drug therapy (118) 118
thiophenes - therapeutic use (118) 118
imaging / radiology (116) 116
endocrinology & metabolism (115) 115
administration, oral (114) 114
double-blind method (114) 114
drug therapy (112) 112
injections, intravenous (111) 111
apoptosis (110) 110
helicobacter pylori (108) 108
sensitivity and specificity (108) 108
drugs (106) 106
in-vitro (106) 106
reproducibility of results (105) 105
drug administration schedule (104) 104
rats, sprague-dawley (103) 103
medicine, general & internal (102) 102
drug combinations (101) 101
disease models, animal (100) 100
exposure (100) 100
organometallic compounds - metabolism (100) 100
brain (99) 99
diagnosis (99) 99
gadolinium - adverse effects (99) 99
lead (99) 99
medicine (99) 99
pentetic acid - analogs & derivatives (99) 99
chemistry (98) 98
osteoporosis (96) 96
radionuclide imaging (96) 96
environmental sciences (95) 95
gadopentetate dimeglumine (95) 95
cardiac & cardiovascular systems (94) 94
anti-bacterial agents - therapeutic use (93) 93
contrast agents (93) 93
antiprotozoal agents - administration & dosage (92) 92
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
UofT at Mississauga - Stacks (10) 10
Chemistry (A D Allen) - Stacks (7) 7
UofT at Scarborough - Stacks (7) 7
Earth Sciences (Noranda) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Searching (1) 1
Online Resources - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3101) 3101
French (42) 42
Russian (40) 40
Spanish (37) 37
German (35) 35
Japanese (30) 30
Portuguese (16) 16
Chinese (10) 10
Italian (10) 10
Polish (5) 5
Czech (3) 3
Danish (2) 2
Dutch (1) 1
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigative Radiology, ISSN 0020-9996, 03/2017, Volume 52, Issue 6, pp. 324 - 333
OBJECTIVESRetrospective studies in patients with primary brain tumors or other central nervous system pathologies as well as postmortem studies have suggested... 
Gadodiamide | Gadobutrol | Gadolinium retention | MRI | Contrast agent | Gadoteridol | Globus pallidus | Histology | Dentate nucleus | Gadopentetate dimeglumine | HEALTHY RATS DIFFERENCE | HIGH-SIGNAL INTENSITY | GLOBUS-PALLIDUS | RENAL-FUNCTION | gadoteridol | contrast agent | dentate nucleus | DEEP CEREBELLAR NUCLEI | gadodiamide | gadolinium retention | T1-WEIGHTED MR-IMAGES | histology | gadopentetate dimeglumine | gadobutrol | ENHANCED MRI | globus pallidus | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROGENIC SYSTEMIC FIBROSIS | Gadolinium - administration & dosage | Injections, Intravenous | Rats, Wistar | Gadolinium - pharmacokinetics | Contrast Media - pharmacokinetics | Male | Muscle, Skeletal - metabolism | Bone and Bones - drug effects | Brain - metabolism | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Bone and Bones - metabolism | Contrast Media - administration & dosage | Mass Spectrometry | Muscle, Skeletal - drug effects | Brain - ultrastructure | Gadolinium DTPA - pharmacokinetics | Models, Animal | Gadolinium DTPA - administration & dosage | Retrospective Studies | Gadolinium DTPA - adverse effects | Heterocyclic Compounds - administration & dosage | Organometallic Compounds - adverse effects | Rodentia | Organometallic Compounds - pharmacokinetics | Rats | Gadolinium - adverse effects | Brain - drug effects | Animals | Heterocyclic Compounds - adverse effects | Skin - ultrastructure | Heterocyclic Compounds - pharmacokinetics | Skin - drug effects | Organometallic Compounds - administration & dosage | Index Medicus | Original
Journal Article
Investigational new drugs, ISSN 0167-6997, 2015, Volume 33, Issue 1, pp. 201 - 214
Background This phase I/II study determined the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics... 
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | TRANS-IMIDAZOLEDIMETHYLSULFOXIDE-TETRACHLORORUTHENATE | DNA-BINDING | METASTASIS | CHEMICAL-STABILITY | TUMORS | PLATINUM COMPLEXES | INHIBITION | LIQUID-CHROMATOGRAPHY | ONCOLOGY | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | CYTOTOXICITY | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 10, pp. 1100 - 1106
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2014, Volume 55, Issue 8, pp. 1248 - 1252
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 12/2011, Volume 38, Issue 12, pp. 2125 - 2135
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors (GEPNETs) are slow-growing, median overall survival ( OS) in patients with... 
LIVER METASTASES | STREPTOZOCIN | CHEMOEMBOLIZATION | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CARCINOID-TUMORS | RADIONUCLIDE THERAPY | ENDOCRINE TUMORS | PHASE-II | METASTATIC NEUROENDOCRINE TUMORS | EPIDEMIOLOGY | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2015, Volume 74, Issue 11, pp. 2062 - 2069
ObjectiveNephrogenic systemic fibrosis (NSF) is a progressive fibrosing disorder that may develop in patients with chronic kidney disease after administration... 
ALTERNATIVELY ACTIVATED MACROPHAGES | TGF-BETA | CONTRAST AGENTS | INTERLEUKIN-1-BETA | DERMAL FIBROBLASTS | NLRP3 INFLAMMASOME | SKIN | RHEUMATOLOGY | POTENTIAL ROLE | NEPHROGENIC SYSTEMIC FIBROSIS | NALP3 INFLAMMASOME | Interleukin-1beta - drug effects | Gadolinium - pharmacology | NLR Family, Pyrin Domain-Containing 3 Protein | Nephrogenic Fibrosing Dermopathy - immunology | Peritoneum - drug effects | Carrier Proteins - drug effects | Contrast Media - pharmacology | Contrast Media - adverse effects | Inflammasomes - drug effects | Peritonitis - genetics | Apoptosis Regulatory Proteins - genetics | Peritoneum - immunology | Carrier Proteins - immunology | Macrophages - immunology | Disease Models, Animal | Interleukin-1beta - secretion | Gadolinium DTPA - pharmacology | Apoptosis Regulatory Proteins - immunology | Gadolinium DTPA - adverse effects | Organometallic Compounds - adverse effects | Mice, Inbred C57BL | Nephrogenic Fibrosing Dermopathy - chemically induced | Interleukin-1beta - immunology | Nephrogenic Fibrosing Dermopathy - genetics | Gadolinium - adverse effects | Peritonitis - chemically induced | Peritonitis - immunology | Mice, Knockout | Carrier Proteins - genetics | Animals | CARD Signaling Adaptor Proteins | Inflammasomes - immunology | Macrophages - drug effects | Mice | Organometallic Compounds - pharmacology | Index Medicus | NLRP3 | macrophages | inflammasome | nephrogenic systemic fibrosis | gadolinium
Journal Article